Michael Crossman Honigberg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Menopause, Premature | 7 | 2023 | 132 | 4.390 |
Why?
|
Pre-Eclampsia | 9 | 2024 | 1200 | 3.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 6 | 2022 | 500 | 2.730 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2024 | 489 | 2.200 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15165 | 1.830 |
Why?
|
Heart Failure | 16 | 2024 | 10900 | 1.410 |
Why?
|
Peripartum Period | 4 | 2022 | 133 | 1.290 |
Why?
|
Eclampsia | 2 | 2023 | 58 | 1.080 |
Why?
|
Coronary Artery Disease | 9 | 2024 | 6487 | 1.080 |
Why?
|
Pericarditis | 2 | 2024 | 128 | 1.070 |
Why?
|
Hypertension | 9 | 2023 | 8480 | 1.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2018 | 552 | 0.920 |
Why?
|
Puerperal Disorders | 3 | 2022 | 275 | 0.900 |
Why?
|
Cardiomyopathies | 5 | 2022 | 1912 | 0.850 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2022 | 3255 | 0.840 |
Why?
|
Menopause | 5 | 2023 | 1626 | 0.790 |
Why?
|
Pregnancy | 22 | 2024 | 29144 | 0.760 |
Why?
|
Lipoprotein(a) | 3 | 2023 | 435 | 0.710 |
Why?
|
Pregnancy Outcome | 4 | 2023 | 2795 | 0.700 |
Why?
|
Prediabetic State | 2 | 2022 | 499 | 0.700 |
Why?
|
Penicillin G Benzathine | 1 | 2018 | 24 | 0.660 |
Why?
|
Postmenopause | 4 | 2023 | 2461 | 0.660 |
Why?
|
Stroke Volume | 8 | 2024 | 5007 | 0.640 |
Why?
|
Atherosclerosis | 3 | 2023 | 3445 | 0.630 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.590 |
Why?
|
Microcirculation | 1 | 2022 | 1286 | 0.590 |
Why?
|
Reproduction | 1 | 2022 | 668 | 0.580 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 712 | 0.580 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2022 | 11725 | 0.550 |
Why?
|
Syphilis | 1 | 2018 | 227 | 0.540 |
Why?
|
Risk Factors | 27 | 2024 | 72290 | 0.540 |
Why?
|
Primary Prevention | 2 | 2021 | 1167 | 0.520 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 732 | 0.510 |
Why?
|
Hypercholesterolemia | 1 | 2022 | 1151 | 0.500 |
Why?
|
Pregnancy Trimesters | 1 | 2015 | 192 | 0.500 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5034 | 0.490 |
Why?
|
Anticholesteremic Agents | 1 | 2022 | 979 | 0.490 |
Why?
|
Female | 51 | 2024 | 380194 | 0.480 |
Why?
|
Antirheumatic Agents | 1 | 2024 | 1339 | 0.480 |
Why?
|
Heart Arrest | 1 | 2024 | 1470 | 0.470 |
Why?
|
Hypertension, Pulmonary | 2 | 2022 | 1537 | 0.460 |
Why?
|
Coronary Aneurysm | 1 | 2016 | 237 | 0.460 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.450 |
Why?
|
Humans | 73 | 2024 | 744343 | 0.450 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5751 | 0.440 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1224 | 0.440 |
Why?
|
Heart Rate | 3 | 2023 | 4091 | 0.430 |
Why?
|
Meningitis | 1 | 2013 | 216 | 0.410 |
Why?
|
Hematopoiesis | 5 | 2023 | 2072 | 0.400 |
Why?
|
Action Potentials | 1 | 2019 | 1806 | 0.400 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2016 | 546 | 0.390 |
Why?
|
Biological Specimen Banks | 5 | 2022 | 711 | 0.380 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2148 | 0.360 |
Why?
|
Melanocytes | 1 | 2013 | 515 | 0.360 |
Why?
|
Coronary Angiography | 2 | 2019 | 4577 | 0.360 |
Why?
|
Blood Glucose | 2 | 2022 | 6256 | 0.360 |
Why?
|
Kidney Diseases | 1 | 2021 | 2149 | 0.360 |
Why?
|
Premature Birth | 1 | 2022 | 1721 | 0.350 |
Why?
|
Adult | 24 | 2023 | 214055 | 0.340 |
Why?
|
Chest Pain | 1 | 2016 | 1114 | 0.340 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 851 | 0.330 |
Why?
|
Women's Health | 4 | 2024 | 2034 | 0.320 |
Why?
|
Electrocardiography | 2 | 2019 | 6442 | 0.320 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 2872 | 0.320 |
Why?
|
Heart Ventricles | 1 | 2020 | 3821 | 0.310 |
Why?
|
Blood Pressure | 5 | 2023 | 8554 | 0.310 |
Why?
|
Coronary Disease | 1 | 2022 | 6077 | 0.290 |
Why?
|
Arrhythmias, Cardiac | 2 | 2022 | 2268 | 0.280 |
Why?
|
Thiazoles | 1 | 2013 | 1483 | 0.270 |
Why?
|
Hormone Replacement Therapy | 2 | 2022 | 745 | 0.260 |
Why?
|
Education, Medical | 1 | 2017 | 1721 | 0.250 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12261 | 0.250 |
Why?
|
Birth Weight | 3 | 2024 | 2069 | 0.250 |
Why?
|
Meningeal Neoplasms | 1 | 2013 | 1241 | 0.240 |
Why?
|
Hyperglycemia | 1 | 2013 | 1373 | 0.240 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 70 | 0.240 |
Why?
|
Hospitalization | 4 | 2022 | 10262 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 15519 | 0.230 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.230 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3843 | 0.220 |
Why?
|
Radon | 1 | 2024 | 81 | 0.220 |
Why?
|
Piperazines | 1 | 2013 | 2488 | 0.210 |
Why?
|
Middle Aged | 20 | 2024 | 213383 | 0.210 |
Why?
|
Mendelian Randomization Analysis | 3 | 2024 | 967 | 0.210 |
Why?
|
Bradycardia | 1 | 2024 | 307 | 0.210 |
Why?
|
Chromosomes, Human, Y | 1 | 2022 | 148 | 0.200 |
Why?
|
Infant, Newborn | 5 | 2023 | 25625 | 0.200 |
Why?
|
Risk Assessment | 2 | 2019 | 23338 | 0.200 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2356 | 0.200 |
Why?
|
Disease Management | 2 | 2022 | 2459 | 0.190 |
Why?
|
Sex Characteristics | 2 | 2022 | 2585 | 0.190 |
Why?
|
Stroke | 4 | 2024 | 9981 | 0.190 |
Why?
|
Receptors, Interleukin-6 | 1 | 2022 | 224 | 0.190 |
Why?
|
Hematologic Neoplasms | 2 | 2023 | 1832 | 0.190 |
Why?
|
Young Adult | 8 | 2023 | 56430 | 0.180 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.180 |
Why?
|
Interleukin-1 | 1 | 2024 | 1263 | 0.180 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7659 | 0.180 |
Why?
|
Dicarboxylic Acids | 1 | 2019 | 69 | 0.180 |
Why?
|
Mosaicism | 1 | 2022 | 441 | 0.180 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3057 | 0.170 |
Why?
|
Chromosomes, Human, X | 1 | 2021 | 296 | 0.170 |
Why?
|
Norway | 1 | 2020 | 448 | 0.170 |
Why?
|
Incidence | 4 | 2021 | 20947 | 0.170 |
Why?
|
Male | 20 | 2024 | 350118 | 0.170 |
Why?
|
Physicians | 1 | 2017 | 4567 | 0.160 |
Why?
|
Prognosis | 4 | 2022 | 29063 | 0.160 |
Why?
|
Quality of Life | 1 | 2020 | 12804 | 0.160 |
Why?
|
Cohort Studies | 7 | 2024 | 40561 | 0.160 |
Why?
|
Sex Factors | 2 | 2022 | 10397 | 0.160 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2022 | 370 | 0.160 |
Why?
|
Gestational Age | 2 | 2018 | 3493 | 0.160 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 528 | 0.160 |
Why?
|
Chronic Disease | 3 | 2019 | 9146 | 0.150 |
Why?
|
Directive Counseling | 1 | 2019 | 166 | 0.150 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.150 |
Why?
|
Ovariectomy | 1 | 2019 | 661 | 0.150 |
Why?
|
Telomere | 1 | 2023 | 910 | 0.150 |
Why?
|
Parity | 1 | 2020 | 929 | 0.150 |
Why?
|
Aspirin | 3 | 2024 | 3282 | 0.150 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2208 | 0.150 |
Why?
|
Doxycycline | 1 | 2018 | 326 | 0.140 |
Why?
|
Mutation | 5 | 2023 | 29786 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 551 | 0.140 |
Why?
|
Aged | 10 | 2024 | 163280 | 0.140 |
Why?
|
Contact Tracing | 1 | 2018 | 273 | 0.140 |
Why?
|
Incidental Findings | 1 | 2021 | 689 | 0.140 |
Why?
|
Sex Distribution | 1 | 2021 | 2297 | 0.130 |
Why?
|
North America | 1 | 2019 | 1249 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 3 | 2023 | 3386 | 0.130 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.130 |
Why?
|
Infant, Small for Gestational Age | 1 | 2018 | 440 | 0.130 |
Why?
|
Leukocytes | 1 | 2023 | 2043 | 0.130 |
Why?
|
Breast Feeding | 1 | 2023 | 1338 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2021 | 1530 | 0.130 |
Why?
|
Age Distribution | 1 | 2021 | 2902 | 0.130 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1782 | 0.130 |
Why?
|
Exercise Tolerance | 1 | 2020 | 770 | 0.130 |
Why?
|
Hyperlipidemias | 1 | 2019 | 789 | 0.120 |
Why?
|
Prospective Studies | 5 | 2024 | 53288 | 0.120 |
Why?
|
Neck | 1 | 2018 | 697 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 964 | 0.120 |
Why?
|
Life Style | 2 | 2023 | 3835 | 0.120 |
Why?
|
Placenta | 1 | 2023 | 1698 | 0.120 |
Why?
|
Neoplasms | 1 | 2022 | 21683 | 0.110 |
Why?
|
Time Factors | 3 | 2019 | 40075 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15076 | 0.110 |
Why?
|
Organizational Innovation | 1 | 2016 | 559 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1184 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2013 | 8863 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1809 | 0.100 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11727 | 0.100 |
Why?
|
Guideline Adherence | 1 | 2022 | 2266 | 0.100 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12959 | 0.090 |
Why?
|
Health Surveys | 1 | 2021 | 4037 | 0.090 |
Why?
|
Retina | 1 | 2021 | 2616 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3670 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2073 | 0.090 |
Why?
|
United States | 8 | 2023 | 69872 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
Thrombosis | 1 | 2024 | 2968 | 0.090 |
Why?
|
Coronary Vessels | 1 | 2021 | 3107 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2021 | 3023 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1972 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3305 | 0.090 |
Why?
|
Brain Ischemia | 1 | 2024 | 3265 | 0.090 |
Why?
|
Overweight | 1 | 2020 | 2371 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1504 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2133 | 0.080 |
Why?
|
Heart | 1 | 2022 | 4467 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2013 | 1850 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.080 |
Why?
|
Recovery of Function | 1 | 2019 | 2925 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12354 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3019 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9687 | 0.080 |
Why?
|
ROC Curve | 1 | 2015 | 3527 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2016 | 1181 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4215 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5952 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 1008 | 0.070 |
Why?
|
Obesity | 4 | 2023 | 12745 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3047 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2015 | 1541 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8089 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.070 |
Why?
|
Genomics | 1 | 2021 | 5720 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 2015 | 1440 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2022 | 7279 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12245 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15540 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9648 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3605 | 0.060 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2046 | 0.060 |
Why?
|
Adrenomedullin | 1 | 2023 | 87 | 0.060 |
Why?
|
Students, Medical | 1 | 2016 | 1862 | 0.060 |
Why?
|
Depression | 1 | 2023 | 7766 | 0.060 |
Why?
|
Apolipoprotein A-I | 1 | 2023 | 281 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 243 | 0.050 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3778 | 0.050 |
Why?
|
Inpatients | 2 | 2022 | 2518 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 403 | 0.050 |
Why?
|
Logistic Models | 1 | 2015 | 13408 | 0.050 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 135 | 0.050 |
Why?
|
Platelet Activation | 1 | 2024 | 673 | 0.050 |
Why?
|
Primary Health Care | 1 | 2016 | 4558 | 0.040 |
Why?
|
Dioxygenases | 1 | 2021 | 316 | 0.040 |
Why?
|
Health Status | 2 | 2023 | 4034 | 0.040 |
Why?
|
Psychotic Disorders | 1 | 2013 | 3046 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.040 |
Why?
|
Eye Proteins | 1 | 2021 | 646 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2023 | 63114 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1814 | 0.040 |
Why?
|
Animals | 4 | 2024 | 168757 | 0.040 |
Why?
|
Demography | 1 | 2021 | 1656 | 0.030 |
Why?
|
Triglycerides | 1 | 2023 | 2454 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1660 | 0.030 |
Why?
|
Child | 1 | 2023 | 77709 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1813 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.030 |
Why?
|
Blood Platelets | 1 | 2024 | 2508 | 0.030 |
Why?
|
Adolescent | 1 | 2021 | 85781 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3558 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 16718 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25043 | 0.030 |
Why?
|
Mice | 3 | 2024 | 81183 | 0.030 |
Why?
|
Recurrence | 1 | 2023 | 8340 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2703 | 0.020 |
Why?
|
Genetic Loci | 1 | 2021 | 2575 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9849 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14557 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4286 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4462 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12951 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1439 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13989 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 8987 | 0.020 |
Why?
|
Patient Care Team | 1 | 2016 | 2531 | 0.020 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8663 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12072 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20129 | 0.010 |
Why?
|